Comparison of a Demand Oxygen Delivery

Comparison of a Demand Oxygen Delivery to Continuous Flow for Administration of Oxygen During Sleep

NCT06609694•Children's Hospital Medical Center, Cincinnati

Summary

Conducting a randomized control trial of oxygen in children with Down syndrome to treat moderate to severe obstructive sleep apnea. The aim of the study is to conduct a comparison between the 2 methods of oxygen delivery during sleep in 15 children from Cincinnati Children's Hospital and Children's Hospital of Los Angeles. 2 polysomnographies will be performed, one with continuous flow and the second with pulse flow.

Detailed Description

Cincinnati Children's Hospital received NIH funding to conduct a randomized control trial of oxygen in children with Down syndrome to treat moderate to severe obstructive sleep apnea. Oxygen may be delivered through continuous flow for the duration of the respiratory cycle or pulse flow during inspiration only. Pulse flow oxygen concentrators have been used clinically in adults. However, there is limited experience with this technology in children. The advantages of pulse flow oxygen concentrator are its portability and its ability in providing compliance data. This is a pilot research study to compare the 2 methods of oxygen delivery during sleep in 15 children from Cincinnati Children's Hospital and Children's Hospital of Los Angeles. 2 polysomnographies will be performed, one with continuous flow and the second with pulse flow. The pilot study is conducted in preparation for a larger project which will include 7 sites aiming at determining the effect of oxygen treatment on the frequency of obstructive apnea, neurocognitive and cardiac outcomes. A separate Institutional Review Board (IRB) protocol of the larger study will be submitted later once approved by the NIH Data and Safety Monitoring Board.

Eligibility

Age

5 - 17 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Age 5-17 years with or without Down Syndrome (DS).
•2. Children with obstructive sleep apnea (OSA) and obstructive apnea hypopnea index (OAHI) 5-40 / hour: The rationale for selecting this range of OAHI is that a large number of children with DS with this range of OSA severity are untreated for months to years. It is important to understand the response to oxygen across the spectrum of disease severity. Notably, children with severe disease are left with few options (e.g., tracheostomy).
•3. Absence of clinically significant hypoxia defined as oxygen saturation \< 88% for 5 minutes or episodic desaturation to 60% as these levels would otherwise identify children eligible to routinely receive oxygen.

Exclusion Criteria

•1. Current CPAP use with documented compliance (\> 4 hrs/ night; \> 70% of nights).
•2. Oxygen saturation \< 90% at rest during wakefulness
•3. Chronic daytime or nighttime use of supplemental oxygen.
•4. Unable to participate in a Polysomnogram (PSG).
•5. Enrolled or planning to enroll in another study that may conflict with protocol requirements or confound results in this trial.

Locations (1)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

Key Dates

Start Date

January 9, 2023

Primary Completion Date

December 1, 2027

Completion Date

December 1, 2028

Last Updated

January 7, 2026

Enrollment

ESTIMATED participants

Conditions

Obstructive Apnea

Interventions

Portable oxygen concentrator Inogen G5 model

DEVICE

Contacts

Suzie Hicks, BS

CONTACT

513-636-4944 suzie.hicks@cchmc.org

Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants

NCT03695900

Apnea of PrematurityDesaturation of Blood+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 7, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions